Oncotarget

Research Papers:

Filamin A phosphorylation by Akt promotes cell migration in response to arsenic

Lingzhi Li _, Yongju Lu, Paul M. Stemmer and Fei Chen

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:12009-12019. https://doi.org/10.18632/oncotarget.3617

Metrics: PDF 1010 views  |   HTML 1339 views  |   ?  


Abstract

Lingzhi Li1, Yongju Lu1, Paul M. Stemmer1,2, Fei Chen1

1Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA

2The Proteomics Core and Institute of Environmental Health Sciences, School of Medicine, Wayne State University, Detroit, MI 48201, USA

Correspondence to:

Fei Chen, e-mail: fchen@wayne.edu

Keywords: arsenic, Akt, filamin A, migration, patient survival

Received: February 12, 2015     Accepted: March 14, 2015     Published: April 03, 2015

ABSTRACT

We had previously reported that trivalent arsenic (As3+), a well-known environmental carcinogen, induces phosphorylation of several putative Akt substrates. In the present report, we characterized one of these substrates by immunoprecipitation and proteomics analysis. The results indicate that a cytoskeleton remodeling protein, filamin A, with a molecular weight around 280 kDa, is phosphorylated by Akt in HEK-293 cells treated with As3+, which was also confirmed in human bronchial epithelial cell line, BEAS-2B cells. Additional biochemical and biological studies revealed that serine 2152 (S2152) of filamin A is phosphorylated by activated Akt in the cells treated with As3+. To further confirm the importance of Akt-dependent filamin A S2152 phosphorylation in As3+-induced cell migration, we over-expressed either wild type filamin A or the mutated filamin A in which the S2152 was substituted with alanine (S2152A). The capability of cell migration was reduced significantly in the cells expressing the mutated filamin A (S2152A). Clinically, we found that increased expression of filamin A predicts poorer overall survival of the lung cancer patients with adenocarcinoma. Thus, these data suggest that Akt dependent filamin A phosphorylation is one of the key events in mediating As3+-induced carcinogenesis. Antagonizing Akt signaling can ameliorate As3+-induced filamin A phosphorylation and cell migration, which may serve as a molecular targeting strategy for malignancies associated with environmental As3+ exposure.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 3617